Table 1.
Clinical, Pathologic, and Treatment Characteristics (n = 20)
| Characteristics | n (%) |
|---|---|
| Age, y | |
| Median (range) | 62 (26–94) |
| Sex | |
| Male | 9 (45) |
| Female | 11 (55) |
| Site | |
| Extremity | 10 (50) |
| Chest/trunk | 6 (30) |
| Retroperitoneal/Abdominal | 4 (20) |
| Presentation status | |
| Primary | 17 (85) |
| Recurrent | 3 (15) |
| Tumor size | |
| <5 cm | 2 (10) |
| 5–10 cm | 12 (60) |
| >10 cm | 6 (30) |
| Histology | |
| NOS | 5 (25) |
| MPNST | 3 (15) |
| GIST | 3 (15) |
| Leiomyosarcoma | 3 (15) |
| Angiosarcoma | 2 (10) |
| Others | 4 (20) |
| Grade | |
| High | 20 (100) |
| Neoadjuvant therapy | |
| Chemoradiation | 9 (45) |
| Chemotherapy | 6 (30) |
| Gleevec | 3 (15) |
| Radiation | 2 (10) |
| Pathologic | |
| Responder | 3 (15) |
| Nonresponder | 17 (85) |
Abbreviations: GIST, gastrointestinal stromal tumor; MPNST, malignant peripheral nerve sheath tumor; NOS, sarcoma not otherwise specified.